rs538758039

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_021098.3(CACNA1H):​c.3425G>A​(p.Arg1142His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000265 in 1,547,178 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1142C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000022 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

5
12
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 7.60

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 16-1209093-G-A is Benign according to our data. Variant chr16-1209093-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 547866.
BS2
High AC in GnomAd4 at 10 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
NM_021098.3
MANE Select
c.3425G>Ap.Arg1142His
missense
Exon 17 of 35NP_066921.2
CACNA1H
NM_001005407.2
c.3425G>Ap.Arg1142His
missense
Exon 17 of 34NP_001005407.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1H
ENST00000348261.11
TSL:1 MANE Select
c.3425G>Ap.Arg1142His
missense
Exon 17 of 35ENSP00000334198.7
CACNA1H
ENST00000569107.6
TSL:1
c.3425G>Ap.Arg1142His
missense
Exon 17 of 34ENSP00000454990.2
CACNA1H
ENST00000711493.1
c.3425G>Ap.Arg1142His
missense
Exon 17 of 34ENSP00000518778.1

Frequencies

GnomAD3 genomes
AF:
0.0000658
AC:
10
AN:
152090
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000686
AC:
10
AN:
145684
AF XY:
0.0000619
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000266
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000511
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000222
AC:
31
AN:
1394972
Hom.:
0
Cov.:
31
AF XY:
0.0000189
AC XY:
13
AN XY:
688876
show subpopulations
African (AFR)
AF:
0.000160
AC:
5
AN:
31200
American (AMR)
AF:
0.000264
AC:
9
AN:
34050
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24670
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36274
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78150
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45636
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5594
European-Non Finnish (NFE)
AF:
0.0000148
AC:
16
AN:
1081628
Other (OTH)
AF:
0.0000173
AC:
1
AN:
57770
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152206
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41530
American (AMR)
AF:
0.000261
AC:
4
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
67980
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000621
AC:
7

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Epilepsy, childhood absence, susceptibility to, 6 (1)
-
-
1
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV (1)
-
-
1
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV (1)
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Uncertain
0.049
T
BayesDel_noAF
Uncertain
0.13
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.61
D
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.41
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.30
D
MetaRNN
Uncertain
0.54
D
MetaSVM
Pathogenic
0.94
D
MutationAssessor
Uncertain
2.9
M
PhyloP100
7.6
PrimateAI
Pathogenic
0.83
D
PROVEAN
Pathogenic
-4.9
D
REVEL
Uncertain
0.56
Sift
Uncertain
0.015
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.58
MutPred
0.23
Loss of MoRF binding (P = 0.064)
MVP
0.96
ClinPred
0.86
D
GERP RS
3.1
Varity_R
0.22
gMVP
0.51
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs538758039; hg19: chr16-1259093; API